Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

schizophrenia

Neuroscience

Neuroscience Weekly News - September 17th 2025

🧠 This Week in Neuroscience: RNAi Tau Therapy CTA, MS Patent Win, Generic…

Public_Health

Public Health Weekly News - September 5th 2025

Public Health Update: Early Alzheimer's Detection, Smartphone Use and…

Neuroscience

Neuroscience Weekly News - June 4th 2025

🧠 This Week in Neuroscience: Breakthroughs in MS, Schizophrenia, Gene Therapy…

LucidQuest Our Work Competitive Intelligence

How we helped a large-size Pharma prepare its sales and medical teams to beat a competitor launch of a new schizophrenia medication.

The Challenge: Gaining insights into competitor's new schizophrenia medication…

Categories

Endocrinology News
Immunology News
Our Insights
Hematology News
Case studies
Oncology News
BioPharma and Tech News
Lucid Diligence Brief
BioPharma Strategy, CI and AI Guides
Conference Coverage
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news
Obesity News

Recent Posts

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

Tags

Acne Research AI diagnostics AI Vaccines Alzheimers Risk Apollo Clinics ARIA-H arthritis therapy Ascletis Avidity Biosciences bioMérieux Boehringer Ingelheim Brain Computer Interface BTK Inhibitors CFTR modulators CNS delivery Competitive Intelligence Companies Depression Research Drug Comparison Dusquetide endocrine disorders Febuxostat GPT-5 Heart Disease Hemlibra hidradenitis suppurativa HLHS Idiopathic Pulmonary Fibrosis Immunotherapy Resistance lamotrigine Legend Lung Disease Lyme vaccine mCRPC MDD medical technology Mosliciguat Ocugen Overall survival Ozuriftamab vedotin respiratory health SAVR Smoking stroke Tzield Viridian Therapeutics

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

TAGS

Acne Research AI diagnostics AI Vaccines Alzheimers Risk Apollo Clinics ARIA-H arthritis therapy Ascletis Avidity Biosciences bioMérieux Boehringer Ingelheim Brain Computer Interface BTK Inhibitors CFTR modulators CNS delivery Competitive Intelligence Companies Depression Research Drug Comparison Dusquetide endocrine disorders Febuxostat GPT-5 Heart Disease Hemlibra hidradenitis suppurativa HLHS Idiopathic Pulmonary Fibrosis Immunotherapy Resistance lamotrigine Legend Lung Disease Lyme vaccine mCRPC MDD medical technology Mosliciguat Ocugen Overall survival Ozuriftamab vedotin respiratory health SAVR Smoking stroke Tzield Viridian Therapeutics

Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy